{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:03:42Z","timestamp":1789916622922,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.yjmcc.2007.06.009","type":"journal-article","created":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T07:29:09Z","timestamp":1183361349000},"page":"337-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"43","author":[{"given":"Christine","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Tebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2007.06.009_bib1","unstructured":"Harvard Medical School\u2014NHLBI program for genomic applications, genomics of cardiovascular development, adaptation and remodeling. www.cardiogenomics.org."},{"issue":"6","key":"10.1016\/j.yjmcc.2007.06.009_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14779072.4.6.927","article-title":"Genetic basis of hypertrophic cardiomyopathy","volume":"4","author":"Lind","year":"2006","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"17","key":"10.1016\/j.yjmcc.2007.06.009_bib3","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.yjmcc.2007.06.009_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"5611","key":"10.1016\/j.yjmcc.2007.06.009_bib5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2007.06.009_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:MCBI.0000041855.10149.5f","article-title":"Calreticulin in the heart","volume":"263","author":"Michalak","year":"2004","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.yjmcc.2007.06.009_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tcm.2006.01.004","article-title":"Assembling pieces of the cardiac puzzle; calreticulin and calcium-dependent pathways in cardiac development, health, and disease","volume":"16","author":"Lynch","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2007.06.009_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/CIRCULATIONAHA.106.623793","article-title":"Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia","volume":"114","author":"di Barletta","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.yjmcc.2007.06.009_bib9","first-page":"2510","article-title":"Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia","volume":"116","author":"Knollmann","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.yjmcc.2007.06.009_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.yjmcc.2007.06.009_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.yjmcc.2007.06.009_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","article-title":"Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy","volume":"48","author":"DeWitt","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2007.06.009_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(03)00526-6","article-title":"Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy","volume":"304","author":"Minamisawa","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2007.06.009_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejheart.2006.04.007","article-title":"Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN-42 C>G mutation","volume":"9","author":"Medin","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.yjmcc.2007.06.009_bib15","first-page":"605","article-title":"Sorcin and ryanodine receptors in heart failure","volume":"25","author":"Valdivia","year":"2004","journal-title":"J. Muscle Res. Cell Motil."},{"issue":"2","key":"10.1016\/j.yjmcc.2007.06.009_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.yjmcc.2004.12.006","article-title":"Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences","volume":"38","author":"Doolan","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2007.06.009_bib17","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.yjmcc.2007.06.009_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-2836(91)90380-O","article-title":"Prediction of human mRNA donor and acceptor sites from the DNA sequence","volume":"220","author":"Brunak","year":"1991","journal-title":"J. Mol. Biol."},{"issue":"11\u201312","key":"10.1016\/j.yjmcc.2007.06.009_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10528-005-9121-8","article-title":"Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a Northern Greek population","volume":"43","author":"Kalemi","year":"2005","journal-title":"Biochem. Genet."},{"issue":"7","key":"10.1016\/j.yjmcc.2007.06.009_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat. Rev., Mol. Cell Biol."},{"issue":"31","key":"10.1016\/j.yjmcc.2007.06.009_bib21","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1073\/pnas.0504920102","article-title":"The structure of phospholamban pentamer reveals a channel-like architecture in membranes","volume":"102","author":"Oxenoid","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yjmcc.2007.06.009_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1073\/pnas.0237326100","article-title":"Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase","volume":"100","author":"Toyoshima","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.yjmcc.2007.06.009_bib23","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1073\/pnas.0402801101","article-title":"Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone","volume":"101","author":"Karim","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.yjmcc.2007.06.009_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1083\/jcb.144.5.857","article-title":"Calreticulin is essential for cardiac development","volume":"144","author":"Mesaeli","year":"1999","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.yjmcc.2007.06.009_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1172\/JCI12412","article-title":"Complete heart block and sudden death in mice overexpressing calreticulin","volume":"107","author":"Nakamura","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2007.06.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M","article-title":"Proof of \u201cdisease causing\u201d mutation","volume":"12","author":"Cotton","year":"1998","journal-title":"Hum. Mutat."},{"issue":"7","key":"10.1016\/j.yjmcc.2007.06.009_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-2828(03)00146-9","article-title":"Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden","volume":"35","author":"Morner","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2007.06.009_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/bbrc.1999.1221","article-title":"Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene","volume":"262","author":"Satoh","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.yjmcc.2007.06.009_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2005.10.008","article-title":"Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin","volume":"88","author":"Bos","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.yjmcc.2007.06.009_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","article-title":"Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy","volume":"107","author":"Geier","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2007.06.009_bib31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","article-title":"Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy","volume":"100","author":"Osio","year":"2007","journal-title":"Circ. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282807010887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282807010887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:57:05Z","timestamp":1762667825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282807010887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0022282807010887"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2007.06.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2007.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}